InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (71 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
71
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Bradbury Daniel, Board Chairman. Insider active across 4 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 83 filings have been logged. Breakdown: 0 buy · 71 sells. Total volume traded: €6.9m. Activity tracked since 27 May 2021. The latest transaction was disclosed on 5 February 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Bradbury Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations83 total
13,667 sharesCommon StockSEC:0001628280-26-038476:0
8,673 sharesCommon StockSEC:0001447362-25-000084:0
5,017 shares@ US$28.1731.6% of flowCommon StockSEC:0001447362-25-000016:0
1,530 shares@ US$28.390.5% of flowCommon StockSEC:0001447362-25-000008:0
4,669 shares@ US$30.9511.6% of flowCommon StockSEC:0001447362-24-000190:0
763 shares@ US$34.920.3% of flowCommon StockSEC:0001447362-24-000172:5
375 shares@ US$33.900.1% of flowCommon StockSEC:0001447362-24-000172:2
1,009 shares@ US$35.330.4% of flowCommon StockSEC:0001447362-24-000172:6
287 shares@ US$35.330.1% of flowCommon StockSEC:0001447362-24-000172:8
1,322 shares@ US$33.900.5% of flowCommon StockSEC:0001447362-24-000172:0
375 shares@ US$33.900.1% of flowCommon StockSEC:0001447362-24-000172:1
2,686 shares@ US$34.921.0% of flowCommon StockSEC:0001447362-24-000172:3
763 shares@ US$34.920.3% of flowCommon StockSEC:0001447362-24-000172:4
287 shares@ US$35.330.1% of flowCommon StockSEC:0001447362-24-000172:7
5,017 shares@ US$29.4431.5% of flowCommon StockSEC:0001447362-24-000158:0
5,017 shares@ US$29.0241.5% of flowCommon StockSEC:0001447362-24-000146:0
5,021 shares@ US$26.6471.4% of flowCommon StockSEC:0001447362-24-000135:0
8,636 sharesCommon StockSEC:0001447362-24-000098:0
7,393 shares@ US$24.641.9% of flowCommon StockSEC:0001447362-24-000064:0
761 shares@ US$20.4530.2% of flowCommon StockSEC:0001447362-24-000048:0
2,901 shares@ US$21.450.7% of flowCommon StockSEC:0001447362-24-000037:0
5,294 shares@ US$20.441.1% of flowCommon StockSEC:0001447362-24-000019:0
658 shares@ US$23.200.2% of flowCommon StockSEC:0001447362-24-000012:0
2,751 shares@ US$22.740.7% of flowCommon StockSEC:0001447362-24-000010:0
5,776 shares@ US$20.401.2% of flowCommon StockSEC:0001447362-24-000008:0
25 of 83 declarations
About Bradbury Daniel
BRADBURY DANIEL is Board Chairman and a director of Castle Biosciences INC, ILLUMINA INC, Intercept Pharmaceuticals, INC. and BioMed Realty Trust Inc. He has filed 83 disclosures in total, all within the sampled set, with 0 EUR of purchases and 6905713 EUR of sales over the period from 2016-01-04 to 2026-05-27, with Cession as the most frequent transaction nature.
